Clinical Guidelines

Test

Nina's test - National Cervical Screening Program

Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding

Testing ResourceTile Component:

Resource Tile Component External

ResourceTile Component text

Testing CalloutTile Component:

Subtitle

Title

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. 

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. 

Testing Image Banner:

Test
Testing
Text text text

gives a 404 error on Staging and CMS preview.

Testing Mosaic Tiles

Changes to the National Cervical Screening Program Guidelines to support universal self-collection



Table of Contents

Foreword

Introduction

Summary of recommendations

1. Cervical cancer in Australia

2. The rationale for primary HPV screening

3. Terminology

4. Unsatisfactory cervical screening results

5. Benefits, harms and cost-effectiveness of cervical screening

6. Management of oncogenic HPV test results

7. Colposcopy

8. Management of discordant colposcopic impression, histopathology and referral LBC prediction

9. Management of histologically confirmed low-grade squamous abnormalities

10. Management of histologically confirmed high-grade squamous abnormalities

11. Management of glandular abnormalities

12. Screening in Aboriginal and Torres Strait Islander women 

13. Screening after total hysterectomy

14. Screening in pregnancy

15. Screening in women who have experienced early sexual activity or have been victims of sexual abuse

16. Screening in immune-deficient women

17. Screening in DES-exposed women

18. Signs and symptoms of cervical cancer

19. Psychosocial care

20. Transitioning to the renewed National Cervical Screening Program

Appendices


Please see the Australian Department of Health Cancer Screening website for information about the National Cervical Screening Program (NCSP) and policies on transitioning women to the renewed NCSP.